A. Lechervy

Deep learning prediction of overall survival in glioblastoma patients using pre-chemoradiotherapy MRI and clinical data

Glioblastoma (GBM) exhibits variable treatment response and patients shown a median survival of 15 months. A major challenge lies in the difficulty of reliably assessing treatment response at an early stage, as it can usually only be evaluated on anatomical MRI performed up to three months after the start of treatm...